GRASTIM INJECTION 300MCG
| Product Name | Grastim Injection |
|---|---|
| Strength | 300 mcg |
| Active Ingredient | Filgrastim |
| Drug Class | Granulocyte Colony-Stimulating Factor (G-CSF) |
| Dosage Form | Injection |
| Route of Administration | Subcutaneous/IV (as prescribed) |
| Packaging | Prefilled syringe/vial |
| Manufacturer | Dr. Reddy’s Laboratories |
| Storage Condition | Store at 2°C–8°C; do not freeze |
| Prescription Required | Yes |
| Usage | Prevention and treatment of neutropenia |
GRASTIM INJECTION 300MCG
Grastim Injection 300mcg by Dr. Reddy’s Laboratories is a prescription hematopoietic product containing filgrastim, a granulocyte colony-stimulating factor (G-CSF). It is widely used to reduce the risk of infections in patients undergoing chemotherapy by supporting white blood cell production and maintaining immune function.
The active ingredient, Filgrastim, stimulates the bone marrow to produce neutrophils, critical components of the immune system. By restoring neutrophil counts, Grastim helps patients better tolerate chemotherapy and lowers the likelihood of infection-related complications during cancer treatment.
Grastim 300 mcg Injection is administered under strict medical supervision in a hospital or clinical setting. This prescription-only product ensures consistent potency, safety, and therapeutic effectiveness, making it a reliable option for supporting immune function in patients receiving chemotherapy.
Product Features
-
- Supportive-care oncology injection
- Contains Filgrastim 300 mcg
- Reduces chemotherapy-induced neutropenia
- G-CSF to stimulate white blood cell production
- Sterile injectable formulation
- Suitable for oncology & hematology use
- Manufactured by Dr. Reddy’s Laboratories
- Prescription-required medicine
How It Helps
- Stimulates bone marrow to produce neutrophils
- Reduces the risk of infections during chemotherapy
- Helps restore white blood cell counts effectively
- Supports immune function under medical supervision

Reviews
There are no reviews yet.